Physician profile
Adrian Mark Salazar
NPI 1316209364
$8,625.36
in general payments reported to CMS, 2019-2025
22 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $220 · 2021: $64.90 · 2022: $1,460 · 2023: $2,083 · 2024: $4,579 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,600 · Travel and Lodging: $3,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,600.25 |
| Travel and Lodging | $3,280.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,840.75 | 2022-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Nalu Medical, INC. | $1,316.19 | 2023-2024 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $1,225.07 | 2020-2024 | Superion Indirect Decompression System |
| Curonix LLC | $1,132.58 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $882.82 | 2022-2025 | Proclaim, Eterna |
| Nevro Corp. | $734.08 | 2022-2024 | Senza |
| Abbvie INC. | $420.27 | 2022-2024 | Ubrelvy, Qulipta |
| Spr Therapeutics, INC | $264.35 | 2021-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $145.43 | 2023 | Intracept |
| Medtronic USA, INC. | $134.91 | 2020 | |
| Painteq LLC | $128.88 | 2023 | Painteq |
| Saluda Medical Americas, INC. | $97.91 | 2023 | Evoke Scs |
| Collegium Pharmaceutical, INC. | $47.45 | 2022-2023 | Belbuca |
| Averitas Pharma INC. | $45.90 | 2024-2025 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $42.57 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $37.02 | 2023 | Irrisept |
| Pfizer INC. | $26.67 | 2023 | |
| Biodelivery Sciences International, INC. | $24.87 | 2021 | |
| Integra Lifesciences Corporation | $22.64 | 2023 | Tenoglide |
| Pacira Pharmaceuticals Incorporated | $20.40 | 2023 | Iovera, Zilretta |
| Globus Medical, INC. | $19.19 | 2025 | Senza |
| Merck Sharp & Dohme LLC | $15.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Salazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.